Frontlight ResearchEarly access
Sickle cell disease trials in United States
34 of 133 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationBlood Collection for Research Related to Certain Diseases Involving Blood Vessels
- Where
- Bethesda, Fairfax
- Age
- 18 years to 100 years
- People
- 2,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00047996 - No phaseTaking peopleNatural History of Sickle Cell Disease
- Where
- Bethesda, Washington D.C.
- Age
- 2 years to 90 years
- People
- 3,500
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00081523 - No phaseTaking peopleGenotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
- Where
- Bethesda
- Age
- 18 years to 80 years
- People
- 800
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03685721 - No phaseTaking peopleHPC Offered for PRESERVE Expansion
- Where
- Birmingham, Columbus, Detroit, Duarte, Nashville
- Age
- 12 years to 80 years
- People
- 10
- Run by
- Ossium Health, Inc.
See details and how to joinNCT07145411 - No phaseNot yet taking people in United StatesData Collection For Patients With Sickle Cell Disease
- Where
- Houston
- Age
- 18 years and over
- People
- 500
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07911618 - No phaseTaking peopleBlood Sampling for Research Related to Sickle Cell Disease
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 250
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00542230 - No phaseTaking peopleObservational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 200
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT05213572 - No phaseTaking peopleCollection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- Where
- Bethesda
- Age
- 18 years to 70 years
- People
- 300
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT03937817 - No phaseTaking peopleDietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 80
- Run by
- National Institutes of Health Clinical Center (CC)
See details and how to joinNCT05170412 - No phaseTaking peopleSickle Cell Disease Biofluid Chip Technology (SCD BioChip)
- Where
- Cleveland
- Age
- 12 years and over
- People
- 100
- Run by
- University Hospitals Cleveland Medical Center
See details and how to joinNCT02824471 - No phaseTaking peopleStudy to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
- Where
- Bethesda
- Age
- 2 years to 99 years
- People
- 50
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT06944067 - No phaseTaking peopleATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Where
- Akron, Albuquerque, Atlanta, Austin, Baltimore, Boston, Buffalo, Chapel Hill, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Dayton, Detroit, Gainesville, Green Bay, Greenville, Hartford, Houston, Hyde Park, Indianapolis, Iowa City, Kansas City, Las Vegas, Little Rock, Los Angeles, Memphis, Miami, Milwaukee, Nashville, Newark, New Haven, New Orleans, New York, Norfolk, Oakland, Orlando, Peoria, Philadelphia, Phoenix, Pittsburgh, Providence, Reno, Rochester, Sacramento, San Antonio, San Bernardino, San Diego, San Francisco, Savannah, Scarborough, Seattle, St Louis, St. Petersburg, Tampa, The Bronx, Toledo, Washington D.C., Wilmington, Winston-Salem
- People
- 3,000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT04398628 - No phaseTaking peopleGene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
- Where
- Memphis
- Age
- 8 years and over
- People
- 145
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05810181 - No phaseTaking peoplePeripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
- Where
- Memphis
- Age
- 12 years to 25 years
- People
- 65
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06477289 - No phaseTaking peopleHydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
- Where
- Cincinnati
- People
- 200
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT04093986 - No phaseTaking peopleInvestigation of the Genetics of Hematologic Diseases
- Where
- Memphis
- People
- 1,716
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT02720679 - No phaseTaking peopleSickle Cell Clinical Research and Intervention Program
- Where
- Baton Rouge, Charlotte, Memphis, Peoria
- People
- 10,000
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT02098863 - No phaseTaking peopleComparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Where
- Atlanta, Birmingham, Boston, Buffalo, Chapel Hill, Charlotte, Chicago, Columbus, Hackensack, Houston, Indianapolis, Memphis, New York, Oklahoma City, Philadelphia, Queens, Rochester, San Antonio, St Louis, The Bronx, Washington D.C., Wilmington
- Age
- 3 years to 20 years
- People
- 480 worldwide
- Run by
- University of Rochester
See details and how to joinNCT06941389 - No phaseTaking peopleFunctional Ovarian Reserve in Sickle Cell Disease
- Where
- Memphis
- Age
- 10 years to 18 years
- People
- 440
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07392216 - No phaseTaking peopleSickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
- Where
- Memphis
- Age
- 13 years and over
- People
- 352
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04416178 - No phaseTaking peopleATHNdataset Registry
- Where
- Hickory
- People
- 200,000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT06820515 - No phaseTaking peopleSickle Cell Kidney Biorepository
- Where
- Dallas
- Age
- 18 years to 65 years
- People
- 800
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07064174 - No phaseTaking peopleA Long-term Follow-up Study in Patients Who Received BEAM-101
- Where
- Atlanta, Birmingham, Boston, Charleston, Cleveland, Detroit, Hackensack, Jacksonville, Memphis, Milwaukee, Minneapolis, Nashville, New York, Philadelphia, Phoenix, St Louis
- Age
- 14 years to 37 years
- People
- 50
- Run by
- Beam Therapeutics Inc.
See details and how to joinNCT07373639 - No phaseTaking peopleVerifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
- Where
- Cincinnati
- Age
- 6 months to 6 years
- People
- 130 worldwide
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT07356050 - No phaseTaking peopleData Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- Where
- Pittsburgh
- Age
- 2 months to 60 years
- People
- 50
- Run by
- Paul Szabolcs
See details and how to joinNCT04528355